Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF

IntroductionPolycystic ovary syndrome (PCOS) is a common multifactorial and polygenic disorder of the endocrine system, affecting up to 20% of women in reproductive age with a still unknown etiology. Follicular fluid (FF) represents an environment for the normal development of follicles rich in meta...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luana Sallicandro, Elko Gliozheni, Davide Feudi, Paola Sabbatini, Roberto Maria Pellegrino, Husam B. R. Alabed, Domenico Baldini, Sandro Gerli, Carlo Alviggi, Eliano Cascardi, Ettore Cicinelli, Antonio Malvasi, Bernard Fioretti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
coleção:	Frontiers in Endocrinology
Assuntos:	PCOS (polycystic ovarian syndrome) VIP (vasoactive intestinal peptide) noradrenalin (NA) follicular fluid In Vitro Fertilization (IVF) metabolomic
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1331282/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!